Decreased NAD+ content in human T lymphoblastoid cells treated simultaneously with 2'-deoxycoformycin and 2'-deoxyadenosine.
D002460:Cell Line; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D003839:Deoxyadenosines / Q000494:pharmacology*; D006801:Humans; D009243:NAD / Q000378:metabolism*; D015649:Pentostatin; D012263:Ribonucleosides / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism*
D003839:Deoxyadenosines; D012263:Ribonucleosides; D009243:NAD; D003070:Coformycin; D015649:Pentostatin